×
For best experience we recommend to activate Javascript in your browser.
CDK2AP1 antibody (AA 1-115)
This anti-CDK2AP1 antibody is a Rabbit Polyclonal antibody detecting CDK2AP1 in WB, IHC, ICC and IP. Suitable for Human.
Quick Overview for CDK2AP1 antibody (AA 1-115) (ABIN7615503)
Target
See all CDK2AP1 Antibodies
CDK2AP1
(Cyclin-Dependent Kinase 2 Associated Protein 1 (CDK2AP1))
Reactivity
All reactivities for CDK2AP1 antibodies
Human
Host
All hosts for CDK2AP1 antibodies
Rabbit
Clonality
All clonalities for CDK2AP1 antibodies
Polyclonal
Conjugate
All conjugates for CDK2AP1 antibodies
This CDK2AP1 antibody is un-conjugated
Application
All applications for CDK2AP1 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP)
Product Details anti-CDK2AP1 Antibody
(hide)
Binding Specificity
All epitopes for CDK2AP1 antibodies
AA 1-115
Purpose
Cyclin Dependent Kinase 2 Associated Protein 1 (CDK2AP1) Polyclonal Antibody
Sequence
Met1~Ser115
Characteristics
The Cyclin Dependent Kinase 2 Associated Protein 1 (CDK2AP1) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for CDK2AP1
(hide)
Target
CDK2AP1
(Cyclin-Dependent Kinase 2 Associated Protein 1 (CDK2AP1))
Alternative Name
CDK2AP1
Gene ID
8099
UniProt
O14519
Recently viewed
(hide)
Chat with us , powered by LiveChat